CLPP and hepatocellular carcinoma: In contrast, in advanced HCC and metastatic disease, ClpP is frequently overexpressed and represents a therapeutic vulnerability that can be targeted by small-molecule activators such as ONC206 and ONC212 (Figure 6) [26,39].